METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE | A202001 | TORRENT PHARMACEUTICALS LTD
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition from Lupin Pharmaceuticals, Inc. FDA-2015-P-3404 Lupin Pharmaceuticals, Inc. filed a citizen petition requesting that the FDA determine whether Merck Sharp Dohme's decision to discontinue VYTORIN (Ezetimibe and Atorvastatin) Tablets in strengths of 10 mg/10 mg, 10 mg/20 mg, 10 mg/40 mg, and 10 mg/80 mg constitutes a withdrawal from sale for safety | 505(q) | 2015-09-25 | Withdrawn | Lupin Pharmaceuticals |
Source: Regulations.gov. FDA citizen petitions matched by application number.
No patent or exclusivity listings for this strength.